Primary Recommendations

Zotefoams - New capacity eases bottleneck

May 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The severity of a growing worldwide recession is going to sort out the men from the boys in British industry. Most companies are being forced into dividend cuts and desperate cash conservation. But amid the gloom there are still some beacons of achievement.At its height last year (see the chart below), Zotefoams, the subject of this article, was valued at £312m and traded on a PE in the mid-20s. That rating was warranted because the company is a world leader in cellular material technology: it utilises a unique (patented) production process to make a range of block foam product, which involves impregnating plastic blocks with nitrogen, using a mixture of heat and high pressure. These blocks are then foamed when the nitrogen expand ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Kromek - Ventilators will set FY21 sales ablaze

Argentex

Zotefoams (September 2023)

Zotefoams (April 2023)

Zotefoams (April 2022)

Zotefoams - Big capex plans come to an end (September 2021)

Zotefoams (March 2021)

Zotefoams (September 2020)

Zotefoams - New contract worth possibly 10% to sales (July 2020)

Zotefoams (February 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X